Synthesis, DNA binding ability and anticancer activity of 2-heteroaryl substituted benzimidazoles linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates

Ahmed Kamal, Praveen Kumar Pogula, Mohammed Naseer Ahmed Khan, Bobburi Naga Seshadri, Kokkonda Sreekanth

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

As a continuation of our efforts to develop the benzimidazole-PBD conjugates as potential anticancer agents, a series of heteroaryl substituted benzimidazole linked PBD conjugates has been synthesized and evaluated for their anticancer potential in 60 human cancer cell lines. Most of the compounds exhibited promising anticancer activity and interestingly, compounds 4c and 4d displayed significant activity in most of the cell lines tested. Whereas, compound 4e showed selectivity in renal cancer cells with GI50 values of < 10 and 70 nM against RXF 393 and UO-31 cell lines, respectively. Further, these compounds also showed significant DNA-binding affinity by thermal denaturation study using duplex form of calf thymus (CT) DNA.

Original languageEnglish (US)
Pages (from-to)651-659
Number of pages9
JournalMedicinal chemistry
Volume9
Issue number5
DOIs
StatePublished - Aug 1 2013

Keywords

  • Benzimidazoles
  • Cytotoxicity
  • DNA-binding affinity
  • Pyrrolobenzodiazepine

Fingerprint Dive into the research topics of 'Synthesis, DNA binding ability and anticancer activity of 2-heteroaryl substituted benzimidazoles linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates'. Together they form a unique fingerprint.

Cite this